“Effectiveness of Erythropoiesis-Stimulating Agent Therapy With Oral and Intravenous Iron Supplementation in Achieving Hemoglobin Targets in Stage 5 Chronic Kidney Disease Patients”. JURNAL FARMASIMED (JFM) 9, no. 1 (October 30, 2026): 499–507. Accessed November 1, 2026. https://ejournal.medistra.ac.id/index.php/JFM/article/view/3691.